Clinical Trial: Dasatinib and Quercetin to Treat Fibrotic Non-alcoholic Fatty Liver Disease
Study Status: COMPLETED
Recruit Status: COMPLETED
Condition: NAFLD
Study Type: INTERVENTIONAL
Official Title: Dasatinib and Quercetin, a Combination of Senolytics to Treat Fibrotic Non-alcoholic Fatty Liver Disease - the TRUTH Study
Brief Summary:
To examine the effect of dasatinib plus quercetin on liver fibrosis in individuals with biopsy proven NAFLD with fibrosis by performing a double-blind randomized controlled proof-of-principle study
Read more